ALK and cancer: The Chinese FDA has approved the ADx EML4-ALK fusion diagnostic kit to be used for RT-PCR to detect ALK rearrangements; this assay has also been accepted by the Chinese Anti-cancer Association, but the requirement for fresh frozen tissue samples for extracting RNA has limited the application in clinical practice.